From The Medscape Journal of Medicine
The Changing Shape of Type 2 Diabetes CME

Disclosures

Release Date: June 18, 2008; Valid for credit through June 18, 2009
Credits Available
Physicians - maximum of 1.0 AMA PRA Category 1 Credit(s)™ for physicians

Contents of This CME Activity
    To participate in this internet activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details.
  1. The Changing Shape of Type 2 Diabetes
    Stephen A. Brunton, MD

Go to Test Questions

 
Legal Disclaimer
The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.
Copyright © 2008 Medscape.

 
Medscape
Learning Objectives

Upon completion of this activity, participants will be able to:

  1. Describe the epidemiology of type 2 diabetes
  2. Identify the role of lifestyle changes and weight loss in the management of type 2 diabetes
  3. List recommendations for the management of type 2 diabetes
  4. Describe characteristics of medications currently available for the treatment of type 2 diabetes
Authors and Disclosures

Stephen Brunton, MD
Disclosure: Stephen Brunton, MD, has disclosed that he is on the advisory boards of Amylin Pharmaceuticals Inc., Abbott Laboratories, and Novo Nordisk A/S.


Charles P. Vega, MD
Disclosure: Charles P. Vega, MD, has disclosed that he has served as an advisor or consultant to Novartis, Inc.
 
Medscape
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Medscape, LLC designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Contact This Provider

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.